MedTrace Logo

Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™

NCT05853783 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2024-11-07

No results posted yet for this study

Summary

The purpose of this study is to validate the ability of the STRATICYTE™ predictive model to predict the transformation of oral potentially malignant disorders (OPMDs) to oral squamous cell carcinoma (OSCC) in a retrospective cohort of patients who received biopsies.

Conditions

  • Mouth Diseases

Interventions

OTHER

STRATICYTE™ Test

Assessment for risk of progression to oral cancer

Sponsors & Collaborators

  • The University of Texas Health Science Center, Houston

    collaborator OTHER

  • Loma Linda University

    collaborator OTHER

  • Minnesota Oral & Facial Surgery

    collaborator UNKNOWN

  • University of Alabama at Birmingham

    collaborator OTHER

  • Proteocyte Diagnostics Inc.

    lead INDUSTRY

Principal Investigators

  • Simon W Young, DDS, MD, PhD · UTHealthHouston

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05853783 on ClinicalTrials.gov